Okiact (Ketoprofen Lysine)

Okiact (ketoprofen lysine) is a NSAID that reduces inflammation and pain in several musculoskeletal conditions.

• Rheumatoid arthritis: helps reduce joint swelling, pain and stiffness.
• Osteoarthritis: provides symptomatic relief of joint pain and improves mobility.
• Acute musculoskeletal injury: alleviates pain and inflammation associated with sprains, strains and bruises.
• Post‑operative pain: used as part of multimodal analgesia to control postoperative discomfort.
• Dysmenorrhea: reduces menstrual pain and uterine cramping.

• Ketoprofen lysine is a propionic‑acid class NSAID that reversibly inhibits cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing the synthesis of prostaglandins that mediate inflammation, pain and fever. The lysine salt form enhances gastrointestinal absorption, providing rapid onset of systemic analgesic and anti‑inflammatory effects.

Ketoprofen lysine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness or light‑headedness.
• Skin rash or mild itching.
• Elevated liver enzymes.

Serious or Rare Side Effects

• Peptic ulcer disease or gastrointestinal bleeding.
• Severe skin reactions such as Stevens‑Johnson syndrome.
• Hepatotoxicity or marked liver injury.
• Renal impairment or acute kidney injury.
• Anaphylaxis or severe hypersensitivity reactions.

When using Okiact, consider the following safety measures:

• Assess renal function: patients with impaired kidney function may need dose adjustment.
• Monitor hepatic function: avoid use in active liver disease.
• Evaluate cardiovascular risk: NSAIDs can increase blood pressure and thrombotic events.
• Use gastro‑protective agents: consider co‑prescription in patients with ulcer risk.
• Avoid in late pregnancy: NSAIDs are contraindicated in the third trimester.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ketoprofen lysine can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.
• High‑dose aspirin: heightened risk of gastric ulceration.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce renal protective effects.
• Diuretics (especially loop diuretics): potential for reduced kidney function.
• Lithium: NSAIDs can increase serum lithium levels.
• Methotrexate: reduced clearance may raise toxicity risk.